Would you consider a donation to support Weekend Reads, and our daily work? Thanks in advance.
The week at Retraction Watch featured:
- In 1987, the NIH found a paper contained fake data. It was just retracted.
- ‘A big pain’: Professor up to six retractions for plagiarism and manipulated peer review
- ‘A display of extreme academic integrity’: A grad student who found a key error praises the original author
- Concussion researcher Paul McCrory earns nine more retractions, nearly 40 expressions of concern
Our list of retracted or withdrawn COVID-19 papers is up to 265. There are more than 36,000 retractions in our database — which powers retraction alerts in EndNote, LibKey, Papers, and Zotero. And have you seen our leaderboard of authors with the most retractions lately — or our list of top 10 most highly cited retracted papers?
Here’s what was happening elsewhere (some of these items may be paywalled, metered access, or require free registration to read):
- “Did someone fake nearly 400 pages to harm a professor?”
- “Science has been in a ‘replication crisis’ for a decade. Have we learned anything?”
- “What is going on in Hindawi special issues?”
- “Is it time to review, the review?” A five-part series in Cosmos.
- “Women researchers are cited less than men. Here’s why—and what can be done about it.”
- “Influence of the first-mover advantage on the gender disparities in physics citations.”
- Apparently, neither the peer reviewers nor the editors of this journal noticed that “there is no cell line named IM-9I.”
- “How to Make Experimental Treatment Less of a Gamble.”
- “Perhaps it is time to move on from the idea of journals being the keepers of scientific record.”
- “Princeton dismisses Kevin Kruse plagiarism allegations as ‘careless cutting and pasting.’”
- A journal has retracted a paper a month by a veterinary researcher a month after we reported they would do so.
- “Radiology researchers reported that scientific fraud and other undesirable practices such as publication bias and honorary authorship are relatively common.”
- “Scientific fraud, publication bias, and honorary authorship appear to be non-negligible practices in nuclear medicine.”
- “Moroccan Researchers Move Against Plagiarism After Study Finds It Widespread.”
- “Perceived publication pressure and research misconduct: should we be too bothered with a causal relationship?”
- “Why research integrity matters.”
- “Can AI-estimated article quality be used to rank scholarly documents?”
- “We survey approaches to prevent or discourage the manipulation of peer mechanisms.”
- “[H]ow a dispute over authorship can escalate into employment claims of…unfair dismissal, discrimination and whistleblowing.”
- “Why Peer Review Should Be More Like Meteorology.”
- “A Nobel prizewinner is six times more likely than someone less well known to get a thumbs-up for acceptance…”
- A critic has filed suit against hydroxychloroquine proponent Didier Raoult, alleging defamation.
- “The great convergence – Does increasing standardisation of journal articles limit intellectual creativity?”
- “Manuscripts ‘rejected’ for using rights retention statements.”
- “Why I think ending article-processing charges will save open access.”
- PubPeer turns ten.
Like Retraction Watch? You can make a tax-deductible contribution to support our work, follow us on Twitter, like us on Facebook, add us to your RSS reader, or subscribe to our daily digest. If you find a retraction that’s not in our database, you can let us know here. For comments or feedback, email us at [email protected].
Apparently, neither the peer reviewers nor the editors of this journal noticed that “there is no cell line named IM-9I.”
The authors of three other papers were also convinced that “IM-9I” is a cell-line of human lymphocytes. The third one is definitely a product of a papermill. I haven’t checked the first two.
Long Noncoding RNA SNHG12 Indicates the Prognosis and Accelerates Tumorigenesis of Diffuse Large B-Cell Lymphoma Through Sponging microR-195 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305849/).
MicroRNA-383-5p predicts favorable prognosis and inhibits the progression of diffuse large B-cell lymphoma
(https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114474/)
The effects of the long non-coding RNA MALAT-1 regulated autophagy-related signaling pathway on chemotherapy resistance in diffuse large B-cell lymphoma
(https://pubmed.ncbi.nlm.nih.gov/28292022/)